Take Back Tomorrow HD focuses on one clear mission: ensuring access to life-extending treatments for those affected by Huntington’s Disease.

Funding for Phase III clinical-trial-approved compassionate use treatments and FDA-approved therapies—or their equivalents approved anywhere in the world—as they become available.

Advocacy with regulators, policymakers, insurers, and healthcare leaders to make these treatments accessible and affordable for everyone who qualifies.

Education about the latest treatment developments, clinical milestones, and availability timelines—keeping the HD community informed and empowered.

While fully independent from pharmaceutical companies, we actively track treatment pipelines and regulatory progress to ensure the HD community can access newly approved therapies without delay.